SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Camlin Fine Sciences Ltd. - (Rights Entitlements (REs)) (CAMLIN-RE) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

BSE: 750947 NSE: CAMLIN-RE | Chemicals |

CAMLIN-RE Share Price

17.89 0.00 (0.00%)
As on 21-Jan'25 16:59

Camlin Fine Sciences Ltd. - (Rights Entitlements (REs)) (CAMLIN-RE)

BSE: 750947 NSE: CAMLIN-RE
Key Metrics
Market Cap
₹0 Cr.
P/E Ratio
Price to Book (P/B)
Price to Sales (P/S)
EV/EBITDA
Return on Capital Employed (ROCE)
%
Current Price
₹17.9
Return on Equity (ROE)
%
Return on Assets (ROA)
%
Operating Profit Margin
0%
Net Profit Margin
NAN%
Gross Profit Margin
0%
Book Value per Share
₹0
Sales Growth (YoY)
%
Sales Growth (3 Years)
%
Operating Profit Growth (1 Year)
NA%
Operating Profit Growth (3 Years)
N/A%
Net Profit Growth (1 Year)
NA%
52-Week Low / High
₹17 / 23
Net Profit Growth (3 Years)
N/A%
Dividend Yield
%
Promoter Holding
%
Pledged shares (%)
of Promoter's holding (%)
%

Check Before You Invest

Q.1 Revenue growth of Camlin Fine Sciences Ltd. - (Rights Entitlements (REs))?
Camlin Fine Sciences Ltd. - (Rights Entitlements (REs)) revenue growth is % for FY- , which is in line with its 5 year CAGR of % , indicating stable growth.
Q.1 Promoter shareholding and pledge status of Camlin Fine Sciences Ltd. - (Rights Entitlements (REs))?
Promoters hold % of the Camlin Fine Sciences Ltd. - (Rights Entitlements (REs)), with % of their stake pledged, indicating no pledge risk.
Q.1 Revenue growth of Camlin Fine Sciences Ltd. - (Rights Entitlements (REs)) vs industry peers?
Camlin Fine Sciences Ltd. - (Rights Entitlements (REs)) revenue CAGR is 0.00% , compared to the industry median CAGR of 7.86% , indicating slower growth and losing its market share.
Q.1 Which industry/sub-sector does Camlin Fine Sciences Ltd. - (Rights Entitlements (REs)) belong to?
Camlin Fine Sciences Ltd. - (Rights Entitlements (REs)) belongs to the Chemicals & Fertilizers sector, operating specifically within the Chemicals segment.
Q.1 Stock return of Camlin Fine Sciences Ltd. - (Rights Entitlements (REs)) over the last decade?
Over the last - year(s), the stock has delivered a CAGR of N/A% based on the current price.

DeciZen - make an informed investing decision on CAMLIN-RE

Based on:

M-Cap below 100cr DeciZen not available

Camlin Fine Sciences Ltd. - (Rights Entitlements (REs)) stock performance

Key Ratios
mw4me loader

Is Camlin Fine Sciences Ltd. - (Rights Entitlements (REs)) an attractive stock to invest in?


Login to view analysis.

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Camlin Fine Sciences Ltd. - (Rights Entitlements (REs)) has not performed well majority of the past ten years indicating its past ten year financial track record is not good
Information and data for this Company is currently unavailable.
We assure our users that information and data for the company will be available soon.

Recent Performance Summary

Login to view analysis.
Login to view analysis.

Latest Financials

Standalone Consolidated
TTM EPS (₹) - -
TTM Sales (₹ Cr.) - -
BVPS (₹) - -
Reserves (₹ Cr.) - -
P/BV - -
PE - -
From the Market
52 Week Low / High (₹) 17.11 / 23.20
All Time Low / High (₹) 14.82 / 23.20
Market Cap (₹ Cr.) -
Equity (₹ Cr.) -
Face Value (₹) -
Industry PE -

Management X-Ray

Shareholding Pattern

No Data To Display

Promoter's Holding & Share Pledging

Valuation of CAMLIN-RE - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
data not found
No data found!

Balance Sheet

(All Figures are in Crores.)
data
No data found!

Cash Flow

(All Figures are in Crores.)
data
No data found!

Finance Ratio

data
No data found!

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Camlin Fine Sciences Ltd. - (Rights Entitlements (REs)) FAQs

The current trading price of CAMLIN-RE on 21-Jan-2025 16:59 is ₹17.89.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 20-Jan-2025 the market cap of CAMLIN-RE stood at ₹0.00 Cr

The latest P/E ratio of CAMLIN-RE as of 20-Jan-2025 is 0.00.

The latest P/B ratio of CAMLIN-RE as of 20-Jan-2025 is 0.00.

The 52-week high of CAMLIN-RE is ₹23.20 and the 52-week low is ₹17.11.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of CAMLIN-RE is ₹0.00 ( Cr.) .

About Camlin Fine Sciences Ltd. - (Rights Entitlements (REs))

No data to display
To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×